Gene polymorphisms of NOD1 and interleukin-8 influence the susceptibility to erosive esophagitis in Helicobacter pylori infected Japanese population

Human Immunology

Volumn 73, Issue 11, 2012, Pages 1184-1189

  Oikawa, Tomoyuki ^a   Asano, Naoki ^a   Imatani, Akira ^a   Ohyauchi, Motoki ^a   Fushiya, Jun ^a   Kondo, Yutaka ^a   Abe, Yasuhiko ^a   Koike, Tomoyuki ^a   Iijima, Katsunori ^a   Shimosegawa, Tooru ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 4; DNA; INTERLEUKIN 8;

ADULT; ALLELE; ARTICLE; DNA EXTRACTION; DNA POLYMORPHISM; FEMALE; GENE SEQUENCE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INFECTION SENSITIVITY; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS;

AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; ATROPHY; CASE-CONTROL STUDIES; ESOPHAGITIS; FEMALE; GASTRIC ACID; GASTRIC MUCOSA; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-8; JAPAN; MALE; MIDDLE AGED; NOD1 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84867878725     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.08.004     Document Type: Article

References (39)

1. Dent J., El-Serag H.B., Wallander M.A., Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005, 54:710.
2. Labenz J., Jaspersen D., Kulig M., Leodolter A., Lind T., Meyer-Sabellek W., et al. Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative. Am J Gastroenterol 2004, 99:1652.
3. Kim N., Lee S.W., Cho S.I., Park C.G., Yang C.H., Kim H., et al. The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea. Aliment Pharmacol Ther 2008, 27:173.
4. Raghunath A.S., Hungin A.P., Wooff D., Childs S. Systematic review: the effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis. Aliment Pharmacol Ther 2004, 20:733.
5. Anderson L.A., Murphy S.J., Johnston B.T., Watson R.G., Ferguson H.R., Bamford K.B., et al. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study. Gut 2008, 57:734.
6. McColl K.E., Watabe H., Derakhshan M.H. Role of gastric atrophy in mediating negative association between Helicobacter pylori infection and reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma. Gut 2008, 57:721.
7. Koike T., Ohara S., Sekine H., Iijima K., Abe Y., Kato K., et al. Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut 2001, 49:330.
8. Graham D.Y. The changing epidemiology of GERD: geography and Helicobacter pylori. Am J Gastroenterol 2003, 98:1462.
9. Cremonini F., Di Caro S., Delgado-Aros S., Sepulveda A., Gasbarrini G., Gasbarrini A., et al. Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2003, 18:279.
10. Raghunath A., Hungin A.P., Wooff D., Childs S. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ 2003, 326:737.
11. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H., et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000, 404:398.
12. Machado J.C., Figueiredo C., Canedo P., Pharoah P., Carvalho R., Nabais S., et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003, 125:364.
13. El-Omar E.M., Rabkin C.S., Gammon M.D., Vaughan T.L., Risch H.A., Schoenberg J.B., et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003, 124:1193.
14. Rad R., Dossumbekova A., Neu B., Lang R., Bauer S., Saur D., et al. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 2004, 53:1082.
15. Leung W.K., Chan M.C., To K.F., Man E.P., Ng E.K., Chu E.S., et al. H. pylori genotypes and cytokine gene polymorphisms influence the development of gastric intestinal metaplasia in a Chinese population. Am J Gastroenterol 2006, 101:714.
16. Ikeda S., Sasazuki S., Natsukawa S., Shaura K., Koizumi Y., Kasuga Y., et al. Screening of 214 single nucleotide polymorphisms in 44 candidate cancer susceptibility genes: a case-control study on gastric and colorectal cancers in the Japanese population. Am J Gastroenterol 2008, 103:1476.
17. Queiroz D.M., Guerra J.B., Rocha G.A., Rocha A.M., Santos A., De Oliveira A.G., et al. IL1B and IL1RN polymorphic genes and Helicobacter pylori cagA strains decrease the risk of reflux esophagitis. Gastroenterology 2004, 127:73.
18. Ando T., El-Omar E.M., Goto Y., Nobata K., Watanabe O., Maeda O., et al. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy. Gut 2006, 55:158.
19. Muramatsu A., Azuma T., Okuda T., Satomi S., Ohtani M., Lee S., et al. Association between interleukin-1beta-511C/T polymorphism and reflux esophagitis in Japan. J Gastroenterol 2005, 40:873.
20. Rosenstiel P., Hellmig S., Hampe J., Ott S., Till A., Fischbach W., et al. Influence of polymorphisms in the NOD1/CARD4 and NOD2/CARD15 genes on the clinical outcome of Helicobacter pylori infection. Cell Microbiol 2006, 8:1188.
21. Kutikhin A.G. Role of NOD1/CARD4 and NOD2/CARD15 gene polymorphisms in cancer etiology. Hum Immunol 2011, 72:955.
22. Viala J., Chaput C., Boneca I.G., Cardona A., Girardin S.E., Moran A.P., et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 2004, 5:1166.
23. Strober W., Murray P.J., Kitani A., Watanabe T. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol 2006, 6:9.
24. McGovern D.P., Hysi P., Ahmad T., van Heel D.A., Moffatt M.F., Carey A., et al. Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum Mol Genet 2005, 14:1245.
25. Hysi P., Kabesch M., Moffatt M.F., Schedel M., Carr D., Zhang Y., et al. NOD1 variation, immunoglobulin E and asthma. Hum Mol Genet 2005, 14:935.
26. Ohyauchi M., Imatani A., Yonechi M., Asano N., Miura A., Iijima K., et al. The polymorphism interleukin 8-251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut 2005, 54:330.
27. Armstrong D., Bennett J.R., Blum A.L., Dent J., De Dombal F.T., Galmiche J.P., et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996, 111:85.
28. Dixon M.F., Genta R.M., Yardley J.H., Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996, 20:1161.
29. Hold G.L., Rabkin C.S., Chow W.H., Smith M.G., Gammon M.D., Risch H.A. A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 2007, 132:905.
30. Iijima K., Ohara S., Sekine H., Koike T., Kubota Y., Kato K., et al. A new endoscopic method of gastric acid secretory testing. Am J Gastroenterol 1998, 93:2113.
31. Masamune A., Shimosegawa T., Masamune O., Mukaida N., Koizumi M., Toyota T. Helicobacter pylori-dependent ceramide production may mediate increased interleukin 8 expression in human gastric cancer cell lines. Gastroenterology 1999, 116:1330.
32. Machin D., Campbell M.J., Fayers P., Pinol A. Comparing independent groups for binary, ordered categorical and continuous data. Sample size tables for clinical studies 1997, Willey-Blackwell, P. 18. 2nd ed.
33. Kawaguchi H., Haruma K., Komoto K., Yoshihara M., Sumii K., Kajiyama G. Helicobacter pylori infection is the major risk factor for atrophic gastritis. Am J Gastroenterol 1996, 91:959.
34. Beales I.L., Calam J. Inhibition of carbachol stimulated acid secretion by interleukin 1beta in rabbit parietal cells requires protein kinase C. Gut 2001, 48:782.
35. Amedei A., Cappon A., Codolo G., Cabrelle A., Polenghi A., Benagiano M., et al. The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. J Clin Invest 2006, 116:1092.
36. Padol I.T., Hunt R.H. Effect of Th1 cytokines on acid secretion in pharmacologically characterised mouse gastric glands. Gut 2004, 53:1075.
37. Fox J.G., Beck P., Dangler C.A., Whary M.T., Wang T.C., Shi H.N., et al. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat Med 2000, 6:536.
38. Togawa S., Joh T., Itoh M., Katsuda N., Ito H., Matsuo K., et al. Interleukin-2 gene polymorphisms associated with increased risk of gastric atrophy from Helicobacter pylori infection. Helicobacter 2005, 10:172.
39. Canto E., Ricart E., Busquets D., Monfort D., Garcia-Planella E., Gonzalez D., et al. Influence of a nucleotide oligomerization domain 1 (NOD1) polymorphism and NOD2 mutant alleles on Crohn's disease phenotype. World J Gastroenterol 2007, 13:5446.